CC BY-NC-ND 4.0 · Asian J Neurosurg 2020; 15(02): 315-321
DOI: 10.4103/ajns.AJNS_315_19
Original Article

Ten years' experiences in the treatment of nonaneurysmal subarachnoid hemorrhage: A retrospective analysis of outcome parameters in a single-center study

Mohammed Alhoobi
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Fatma Abu-Qadous
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Mohsin Khan
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Ahmed Shaaban
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Nissar Shaikh
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Firas Hammadi
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Raed Abu-Jarir
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Walid Albanna
1   Department of Neurosurgery, RWTH, Aachen University, Aachen
,
Ghaya Alrumaihi
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Sirajelddin Belkhair
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Arun Babu
Department of Neurosurgery, Hamad Medical Corporation, Doha
,
Ali Ayyad
Department of Neurosurgery, Hamad Medical Corporation, Doha
› Author Affiliations

Objectives: Subarachnoid hemorrhage (SAH) with negative angiographic findings has a heterogeneous nature with variations in clinical course and outcome as compared to the aneurysmal SAH. It makes up to 15% of the spontaneous SAH and is characterized by milder clinical presentation. The purpose of this study was the analyses of risk factors, clinical observations, radiologic characteristics, and outcome in patients with nonaneurysmal SAH (NA-SAH). Patients and Methods: In a retrospective design, 77 consecutive patients with NA-SAH were recruited from May 2008, to October 2018. All patients underwent conventional cerebral angiography. We stratified patients into two groups based on the distribution of blood on their CT scan into perimesencephalic (PM) and non-PM (NPM) SAH. We performed the Outcome using Glasgow Coma Scale (GCS) and modified Rankin scale (favorable mRS 0–2 vs. unfavorable mRS 3–6). Data were analyzed using IBM® SPSS® Statistics V22.0. Results: The mean age at presentation was 48.5 ± 8.4 years with male predominance (71.4%). About 76.7% of the patients had headache and vomiting, most of the patients (75.3%) presented with GCS 15 at initial clinical presentation (61.03%) had NPM versus (38.96%) with PM characters in computed tomography scans. Fourteen (17.9%) patients developed hydrocephalus and 12 (15.3%) needed external ventricular drain placement, while none of the patients needed permanent shunt placement. However, all patients had a favorable clinical and functional outcome at discharge and at late follow-up (up to 3 months). Conclusions: NA-SAH does not affect the short- and long-term prognosis. In our results, the pattern of bleeding affects the initial presentation, clinical course, and complications. The clinical and functional outcomes in the majority of our patients were comparable in both groups with good prognosis. Hypertension, smoking, and elevated venous pressure, such as a history of deep venous thrombosis and asthma might be considered as a risk factor.

Financial support and sponsorship

Nil.




Publication History

Received: 22 October 2019

Accepted: 16 January 2020

Article published online:
16 August 2022

© 2020. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: Diagnosis, causes and management. Brain 2001;124:249-78.
  • 2 Gupta SK, Gupta R, Khosla VK, Mohindra S, Chhabra R, Khandelwal N, et al. Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: Is it a benign entity? Surg Neurol 2009;71:566-71.
  • 3 Ruigrok YM, Rinkel GJ, Buskens E, Velthuis BK, van Gijn J. Perimesencephalic hemorrhage and CT angiography: A decision analysis. Stroke 2000;31:2976-83.
  • 4 Bakker NA, Groen RJ, Foumani M, Uyttenboogaart M, Eshghi OS, Metzemaekers JD, et al. Repeat digital subtraction angiography after a negative baseline assessment in nonperimesencephalic subarachnoid hemorrhage: A pooled data meta-analysis. J Neurosurg 2014;120:99-103.
  • 5 Delgado Almandoz JE, Jagadeesan BD, Refai D, Moran CJ, Cross DT 3rd, Chicoine MR, et al. Diagnostic yield of repeat catheter angiography in patients with catheter and computed tomography angiography negative subarachnoid hemorrhage. Neurosurgery 2012;70:1135-42.
  • 6 Ildan F, Tuna M, Erman T, Göçer AI, Cetinalp E. Prognosis and prognostic factors in nonaneurysmal perimesencephalic hemorrhage: A follow-up study in 29 patients. Surg Neurol 2002;57:160-5.
  • 7 van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: A nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985;35:493-7.
  • 8 Sandvei MS, Mathiesen EB, Vatten LJ, Müller TB, Lindekleiv H, Ingebrigtsen T, et al. Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984-2007. Neurology 2011;77:1833-9.
  • 9 Beseoglu K, Pannes S, Steiger HJ, Hänggi D. Long-term outcome and quality of life after nonaneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2010;152:409-16.
  • 10 Kumar S, Goddeau RP Jr., Selim MH, Thomas A, Schlaug G, Alhazzani A, et al. Atraumatic convexal subarachnoid hemorrhage: Clinical presentation, imaging patterns, and etiologies. Neurology 2010;74:893-9.
  • 11 Kang DH, Park J, Lee SH, Park SH, Kim YS, Hamm IS. Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis? J Clin Neurosci 2009;16:904-8.
  • 12 Hui FK, Tumialán LM, Tanaka T, Cawley CM, Zhang YJ. Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage. Neurocrit Care 2009;11:64-70.
  • 13 Renou P, Tourdias T, Fleury O, Debruxelles S, Rouanet F, Sibon I. Atraumatic nonaneurysmal sulcal subarachnoid hemorrhages: A diagnostic workup based on a case series. Cerebrovasc Dis 2012;34:147-52.
  • 14 Rinkel GJ, Wijdicks EF, Hasan D, Kienstra GE, Franke CL, Hageman LM, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991;338:964-8.
  • 15 Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group. Stroke 2010;41:2391-5.
  • 16 Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994;25:1342-7.
  • 17 Kapadia A, Schweizer TA, Spears J, Cusimano M, Macdonald RL. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: Diagnosis, pathophysiology, clinical characteristics, and long-term outcome. World Neurosurg 2014;82:1131-43.
  • 18 Kleinpeter G, Lehr S. Characterization of risk factor differences in perimesencephalic subarachnoid hemorrhage. Minim Invasive Neurosurg 2003;46:142-8.
  • 19 Kong Y, Zhang JH, Qin X. Perimesencephalic subarachnoid hemorrhage: Risk factors, clinical presentations, and outcome. Acta Neurochir Suppl 2011;110:197-201.
  • 20 Boswell S, Thorell W, Gogela S, Lyden E, Surdell D. Angiogram-negative subarachnoid hemorrhage: Outcomes data and review of the literature. J Stroke Cerebrovasc Dis 2013;22:750-7.
  • 21 Dalyai R, Chalouhi N, Theofanis T, Jabbour PM, Dumont AS, Gonzalez LF, et al. Subarachnoid hemorrhage with negative initial catheter angiography: A review of 254 cases evaluating patient clinical outcome and efficacy of short-and long-term repeat angiography. Neurosurgery 2013;72:646-52.
  • 22 Pyysalo LM, Niskakangas TT, Keski-Nisula LH, Kähärä VJ, Öhman JE. Long term outcome after subarachnoid haemorrhage of unknown aetiology. J Neurol Neurosurg Psychiatry 2011;82:1264-6.
  • 23 Canhão P, Ferro JM, Pinto AN, Melo TP, Campos JG. Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms. Acta Neurochir (Wien) 1995;132:14-9.
  • 24 Available from: https://knoema.com/atlas/Qatar/topics/Demographics/Population/Male-to-female-ratio. [Last accessed on 2019 Oct 22].
  • 25 Konczalla J, Platz J, Schuss P, Vatter H, Seifert V, Güresir E. Non-aneurysmal non-traumatic subarachnoid hemorrhage: Patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients. BMC Neurol 2014;14:140.
  • 26 Sheehan JM, Cloft H, Kassell NF. Symptomatic delayed arterial spasm following non-aneurysmal perimesencephalic subarachnoid hemorrhage: A case report and review of the literature. Acta Neurochir (Wien) 2000;142:709-12.
  • 27 Cánovas D, Gil A, Jato M, de Miquel M, Rubio F. Clinical outcome of spontaneous non-aneurysmal subarachnoid hemorrhage in 108 patients. Eur J Neurol 2012;19:457-61.